<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM/HYPOTHESIS: Glucagon-like <z:chebi fb="7" ids="16670">peptide</z:chebi>-1 (GLP-1) is metabolised by the enzyme dipeptidyl-peptidase 4 (DPP-4), generating a metabolite with potential antagonistic properties </plain></SENT>
<SENT sid="1" pm="."><plain>This study was conducted to evaluate the effect of that metabolite on plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: The randomised crossover study consisted of five regimens: (1) i.v. infusion of GLP-1 (1.2 pmol kg(-1) min(-1); IV); (2 and 3) s.c. infusion of GLP-1 (2.4 and 9.6 pmol kg(-1) min(-1); LSC, <z:chebi fb="15" ids="50443">HSC</z:chebi>); (4) s.c. infusion of GLP-1 (2.4 pmol kg(-1) min(-1)) in combination with a DPP-4 inhibitor (IB); and (5) s.c. infusion of saline (154 mmol <z:chebi fb="1" ids="26710">NaCl</z:chebi>/l; SAL) </plain></SENT>
<SENT sid="3" pm="."><plain>Seven patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> participated in <z:hpo ids='HP_0000001'>all</z:hpo> protocols </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Plasma levels of intact GLP-1 increased from 7+/-1 (SAL) to 17+/-3 (LSC), 61+/-7 (IB), 62+/-5 (IV) and 94+/-10 (9.6 s.c.) pmol/l, p&lt;0.0001 </plain></SENT>
<SENT sid="5" pm="."><plain>Plasma concentrations of the metabolite increased from 1+/-3 (SAL) and 2+/-6 (IB) pmol/l to 42+/-4 (LSC), 64+/-8 (IV) and 327+/-16 (<z:chebi fb="15" ids="50443">HSC</z:chebi>) pmol/l, p&lt;0.0001 </plain></SENT>
<SENT sid="6" pm="."><plain>Mean plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels at 6 h decreased from 12.4+/-1.1 (SAL) mmol/l to 10.4+/-1.1 (LSC), 8.6+/-0.6 (IB), 8.8+/-0.8 (IV) and 9.1+/-0.9 (<z:chebi fb="15" ids="50443">HSC</z:chebi>) mmol/l, p&lt;0.0001 </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS/INTERPRETATION: At approximately similar concentrations of intact GLP-1 (IV, IB, <z:chebi fb="15" ids="50443">HSC</z:chebi>), but with widely ranging metabolite concentrations, the effect on plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels was equal, indicating that the presence of the metabolite does not antagonise the <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering effect of GLP-1 </plain></SENT>
</text></document>